Tandem Diabetes Care to Present at Canaccord Growth Conference
Event summary
- Tandem Diabetes Care will present at the Canaccord Genuity’s 46th Annual Growth Conference on August 11, 2026.
- The presentation will be webcast live and archived for 30 days.
- Tandem offers advanced automated insulin delivery systems including the Tandem Mobi system and t:slim X2 pump.
The big picture
Tandem Diabetes Care’s upcoming presentation at Canaccord Genuity’s Growth Conference highlights its strategic focus on advancing diabetes technology. The event comes amid increasing competition in automated insulin delivery systems, where differentiation through innovation is critical. Tandem’s ability to scale its product portfolio and maintain market leadership will be key themes for investors.
What we're watching
- Product Differentiation
- How Tandem’s Control-IQ+ technology will be positioned against competitors in the automated insulin delivery space.
- Market Expansion
- Whether Tandem can sustain growth in global markets beyond its U.S. base.
- Investor Sentiment
- The impact of the conference presentation on investor confidence and stock performance.
Related topics